Number IV erythema multiforme

被引:56
作者
Farthing, P
Bagan, JV
Scully, C
机构
[1] UCL, Eastman Dent Inst, London WC1X 8LD, England
[2] Univ Sheffield, Charles Clifford Dent Sch, Sheffield, S Yorkshire, England
[3] Univ Valencia, Univ Hosp, E-46003 Valencia, Spain
关键词
erythema multiforme; autoimmune; immunosuppressants; oral; vesiculobullous; skin;
D O I
10.1111/j.1601-0825.2005.01141.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Erythema multiforme (EM) is an acute mucocutaneous hypersensitivity reaction characterised by a skin eruption, with or without oral or other mucous membrane lesions. Occasionally EM may involve the mouth alone. EM has been classified into a number of different variants based on the degree of mucosal involvement and the nature and distribution of the skin lesions. EM minor typically affects no more than one mucosa, is the most common form and may be associated with symmetrical target lesions on the extremities. EM major is more severe, typically involving two or more mucous membranes with more variable skin involvement-which is used to distinguish it from Stevens-Johnson syndrome (SJS), where there is extensive skin involvement and significant morbidity and a mortality rate of 5-15%. Both EM major and SJS can involve internal organs and typically are associated with systemic symptoms. Toxic epidermal necrolysis (TEN) may be a severe manifestation of EM, but some experts regard it as a discrete disease. EM can be triggered by a number of factors, but the best documented is preceding infection with herpes simplex virus (HSV), the lesions resulting from a cell mediated immune reaction triggered by HSV-DNA. SJS and TEN are usually initiated by drugs, and the tissue damage is mediated by soluble factors including Fas and FasL.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 45 条
[21]   Idiosyncratic drug reactions: the reactive metabolite syndromes [J].
Knowles, SR ;
Uetrecht, J ;
Shear, NH .
LANCET, 2000, 356 (9241) :1587-1591
[22]  
Kokuba H, 1998, BRIT J DERMATOL, V138, P952
[23]   Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme: Viral gene expression and T cell repertoire usage [J].
Kokuba, H ;
Imafuku, S ;
Burnett, JW ;
Aurelian, L .
DERMATOLOGY, 1999, 198 (03) :233-242
[24]   RECURRENT AND CONTINUOUS ERYTHEMA MULTIFORME - A CLINICAL AND IMMUNOLOGICAL STUDY [J].
LEIGH, IM ;
MOWBRAY, JF ;
LEVENE, GM ;
SUTHERLAND, S .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1985, 10 (01) :58-67
[25]   ERYTHEMA MULTIFORME - CLINICAL CHARACTERISTICS AND NATURAL-HISTORY IN 50 PATIENTS [J].
LOZADA, F ;
SILVERMAN, S .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1978, 46 (05) :628-636
[26]   DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS .1. AN OVERVIEW [J].
LYELL, A .
CLINICS IN DERMATOLOGY, 1993, 11 (04) :491-492
[27]   TOXIC EPIDERMAL NECROLYSIS (THE SCALDED SKIN SYNDROME) - REAPPRAISAL [J].
LYELL, A .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 100 (01) :69-+
[28]  
MALMSTROM M, 1990, ACTA DERM-VENEREOL, V70, P405
[29]   DETECTION OF VIRAL-DNA WITHIN SKIN OF HEALED RECURRENT HERPES-SIMPLEX INFECTION AND ERYTHEMA MULTIFORME LESIONS [J].
MIURA, S ;
SMITH, CC ;
BURNETT, JW ;
AURELIAN, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (01) :68-72